# Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI

> **NCT05545605** · NA · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 116 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Sodium oligomannate
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT05545605
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05545605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05545605, "Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05545605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*